期刊文献+

金匮肾气丸对去势大鼠骨微结构及ALP、OPG、IL-6的影响 被引量:21

Effects of Jinkui Shenqi pill on bone microstructure and ALP,OPG,IL-6 in ovariectomized rats
下载PDF
导出
摘要 目的研究金匮肾气丸防治骨质疏松的机制,探讨“温补肾阳,以生髓壮骨”中医理论在绝经后骨质疏松中的应用。方法采用卵巢切除法复制绝经后骨质疏松大鼠模型,随机分为模型组、金匮肾气丸高、低剂量组、雌二醇组,同时设置假手术组作为对照组,各组分别给予相应的药物灌胃。给药3月后处死取材,计算子宫系数;HE染色观察子宫的病理变化;Micro-CT检测大鼠骨密度及骨微结构的变化;全自动生化分析仪检测各组大鼠血清中血糖、血脂及钙磷的变化;ELISA检测各组大鼠血清中ALP、IL-6及OPG表达的变化。结果与假手术组相比,模型组大鼠骨密度显著下降(P<0.05),骨微结构破坏明显;与模型组相比,金匮肾气丸低剂量组大鼠骨密度得到了有效提高、骨微结构获得改善,血糖、血脂水平降低,血清中钙磷的含量明显提高,血清中ALP、IL-6含量降低,OPG含量升高。结论金匮肾气丸能够提高去卵巢大鼠的骨量,防治绝经后骨质疏松症,其作用机理可能与降低ALP、IL-6,提高OPG含量有关。 Objective To study the mechanism of Jinkui Shenqi Pill in preventing and treating osteoporosis,and to explore the application of TCM theory of“warming kidney-yang and strengthening bones with marrow”in postmenopausal osteoporosis.Methods Postmenopausal osteoporosis rats were induced by ovariectomy.The rats were randomly divided into model group,Jinkui Shenqi pill high dose group,low dose group and estradiol group.At the same time,the sham-operated group served as control group.After 3 months of administration,samples were collected and the uterus coefficient was calculated;pathological changes of uterus were observed by HE staining;changes of bone mineral density and bone microstructure were detected by Micro-CT;changes of blood glucose,blood lipid and calcium and phosphorus in serum were detected by automatic biochemical analyzer;changes of ALP,IL-6 and OPG expression in serum were detected by ELISA.Results Compared with the sham-operated group,the rats in the model group had significantly decreased bone mineral density(P<0.05)and significantly damaged bone microstructure;compared with the model group,the rats in the Jinkui Shenqi pill low dose group had effectively increased bone mineral density,improved bone microstructure,decreased blood glucose and blood lipid levels,significantly increased calcium and phosphorus content in serum,decreased ALP and IL-6 content in serum,and increased OPG content.Conclusion Jinkui Shenqi pill can increase bone mass and prevent postmenopausal osteoporosis in ovariectomized rats,and its mechanism may be related to decreasing ALP,IL-6 and increasing OPG content.
作者 张倩 杨旭 王媛 王世军 王花欣 ZHANG Qian;YANG Xu;WANG Yuan;WANG Shijun;WANG Huaxin(Shandong University of Traditional Chinese Medicine, Jinan 250355, China;Shandong Co-Innovation Center of Classic TCM formula, Jinan 250355, China)
出处 《中国骨质疏松杂志》 CAS CSCD 北大核心 2020年第10期1475-1480,共6页 Chinese Journal of Osteoporosis
基金 山东省中医药科技发展计划项目(2017-004) 山东省高等学校科技计划项目(J18KA271) 山东省自然科学基金重大基础研究项目(ZR2019ZD23)。
关键词 金匮肾气丸 绝经后骨质疏松症 雌激素 骨密度 Jinkui Shenqi pill postmenopausal osteoporosis estrogen bone mineral density
  • 相关文献

参考文献17

二级参考文献144

  • 1林兰.中西医结合糖尿病诊疗标准(草案)[J].中国中西医结合杂志,2005,25(1):94-95. 被引量:248
  • 2傅延龄,刘渡舟.抓主症方法的认识与运用[J].中国医药学报,1993,8(4):43-44. 被引量:30
  • 3杨帆,徐妙容,杨妙馥,林志恒,刘满堂,袁志辉.中药治疗骨质疏松症的用药规律(英文)[J].中国临床康复,2005,9(31):203-205. 被引量:6
  • 4王锡娟,梁日欣,赵璐,高伟.中药复方骨疏康防治骨质疏松症研究进展[J].中国中西医结合杂志,2007,27(3):282-285. 被引量:12
  • 5Torrens J I, Sutton-Tyrrell K,Zhao X, et al. Relative androgen excess during the menopausal transition predicts incident metabolic syndrome in midlife women:study of Women's Health Across the Nation[J]. Menopause, 2009, 16(2):257-264.
  • 6Gogos A,van den Buuse M. Comparing the effects of 176- oestradiol and the selective oestrogen receptor modula- tors,raloxifene and tamoxifen,on prepulse inhibition in female rats [J]. Schizophrenia Research,2015,168 (3) : 634-639.
  • 7Van Pelt RE,Gozansky WS,Wolfe P,et al. Estrogen or raloxifene during postmenopausal weight loss:adiposity and cardiometabolic outcomes[J]. Obesity(Silver Spring), 2014,22(4):1024-1031.
  • 8Barros RP,Gustafsson JA. Estrogen receptors and the metabolic network [J]. Cell Metab, 2011,14(3) : 289-299.
  • 9Haverkamp F, Gasteyger C. A review of biopsychosocial strategies to prevent and overcome early-recognized poor adherence in growth hormone therapy of children [J]. J Med Econ,2011,14(4) :448-457.
  • 10Faulds MH,Zhao C, Dahlman-Wright K, et al. The diver- sity of sex steroid action:regulation of metabolism by es- trogen signaling [ J ]. J Endocrinol, 2012,212 ( 1 ) : 3-12.

共引文献575

同被引文献363

引证文献21

二级引证文献127

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部